Following the European Parliament’s plenary vote on the sixth revision of the Carcinogens, Mutagens and Reprotoxic Substances Directive (CMRD 6) on 6 October, the European Federation of Nurses Associations (EFN), the European Federation of Public Service Unions… Read more
European Parliament Adopts Report on EU Health Workforce Crisis, Recognising Risks from Hazardous Medicinal Products
The European Parliament has adopted its own-initiative report “on an EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector” at plenary on 17 September 2026. The European… Read more
EBN Op-Ed on Occupational Exposure to Hazardous medicinal products (HMPs) Published in Social Europe
The European Biosafety Network is delighted to feature in Social Europe with an op-ed co-authored by Josh Cobb and Patrick Jahn, on the gap between EU law and ward-level practice in protecting nurses from hazardous medicinal products (HMPs). Read more
European guidance on hazardous medicinal products now available in 24 EU languages
The European Commission’s guidance on the safe management of hazardous medicinal products (HMPs) at work is now available in 24 EU languages. The guidance sets out practical measures to protect healthcare workers from occupational exposure to hazardous drugs,… Read more
Webinar: Formaldehyde Exposure in Healthcare – Risks, Regulation and Practical Solutions
We are delighted to share that our webinar examining the occupational risks of formaldehyde exposure in healthcare, hosted by the European Biosafety Network, had over 100 attendees across a range of professions. Attendees heard from Dr Acran Selman… Read more
EBN, EFN and EPSU publish a joint statement as CMRD 6 passes without Annex I inclusion, leaving healthcare professionals handling hazardous medicinal products unprotected
6 July 2026 Healthcare Professionals Handling Hazardous Medicinal Products Remain Unprotected as CMRD 6 Passes Without Annex I Inclusion Every day, nurses, pharmacists and many other healthcare professionals across Europe are exposed to hazardous chemotherapy drugs and… Read more
EBN Presents at BeSEDiM Webinar on Needle Safety
On 18 June 2026, Dr Philip Bickford Smith presented on behalf of the European Biosafety Network at An Evening with the Belgian Society of Emergency & Disaster Medicine (BeSEDiM): ‘Quality & Safety in EM: It’s Hot in… Read more
EBN, EFN and EPSU urge European Commission to support Annex I inclusion of hazardous medicinal products ahead of CMRD 6 trilogue
The European Biosafety Network, together with the European Federation of Nurses Associations (EFN), and the European Federation of Public Service Unions (EPSU), on behalf of the Stop Cancer At Work (SCAW) campaign has written jointly to the European Commission… Read more
EBN calls for dedicated EU action on hazardous medicinal products in EU4Health 2027
The European Biosafety Network has submitted a formal response to the European Commission’s targeted stakeholder consultation on the EU4Health work programme 2027, calling for the prevention of occupational exposure to hazardous medicinal products (HMPs) to be established as a… Read more
Webinar: Protecting Healthcare Workers from Formaldehyde Exposure: Risks, Regulation, and Solutions
Join us for a webinar on Thursday 2 July, 13:00 – 14:00 CET examining the occupational risks of formaldehyde exposure in healthcare and the practical steps organisations can take to protect their workforce. This webinar will… Read more
